Prati
Xingyue An
Xingyue An
EvolveImmune Therapeutics, Inc
Potvrđena adresa e-pošte na evolveimmune.com
Naslov
Citirano
Citirano
Godina
CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
K Fousek, J Watanabe, SK Joseph, A George, X An, TT Byrd, JS Morris, ...
Leukemia 35 (1), 75-89, 2021
1372021
Single-dose intranasal vaccination elicits systemic and mucosal immunity against SARS-CoV-2
X An, M Martinez-Paniagua, A Rezvan, SR Sefat, M Fathi, S Singh, ...
Iscience 24 (9), 2021
712021
Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells
X An, VG Sendra, I Liadi, B Ramesh, G Romain, C Haymaker, ...
PLoS One 12 (8), e0181904, 2017
472017
Single-cell cloning of breast cancer cells secreting specific subsets of extracellular vesicles
M Fathi, R Joseph, JRT Adolacion, M Martinez-Paniagua, X An, ...
Cancers 13 (17), 4397, 2021
192021
Targeting primary pre-B cell acute lymphoblastic leukemia and CD19-negative relapses using trivalent CAR T cells
K Fousek, J Watanabe, A George, X An, H Samaha, SA Navai, TT Byrd, ...
Blood 130, 4614, 2017
192017
Designed improvement to T-cell immunotherapy by multidimensional single cell profiling
IN Bandey, JRT Adolacion, G Romain, MM Paniagua, X An, A Saeedi, ...
Journal for immunotherapy of cancer 9 (3), 2021
142021
Single-cell technologies for profiling T cells to enable monitoring of immunotherapies
X An, N Varadarajan
Current opinion in chemical engineering 19, 142-152, 2018
102018
Targeting CD19-negative relapsed B-acute lymphoblastic leukemia using trivalent CAR T cells.
K Fousek, J Watanabe, A George, X An, HS Samaha, SA Navai, TT Byrd, ...
Journal of Clinical Oncology 36 (5_suppl), 121-121, 2018
92018
CAR+ T cell anti-tumor efficacy revealed by multi-dimensional single-cell profiling
X An, G Romain, M Martinez-Paniagua, IN Bandey, JRT Adolacion, ...
The Journal of Immunology 202 (1_Supplement), 134.2-134.2, 2019
22019
T-cell potential for CD19-expressing malignancies revealed by multi-dimensional single-cell profiling
A Rezvan, G Romain, M Fathi, D Heeke, M Martinez-Paniagua, X An, ...
bioRxiv, 2022.06. 22.497245, 2022
12022
Abstract A50: Trivalent CAR T cells mitigate CD19-negative relapse and improve tumor control in primary pre-B cell acute lymphoblastic leukemia (B-ALL)
K Fousek, J Watanabe, X An, A George, H Samaha, S Navai, TT Byrd, ...
Cancer Immunology Research 6 (9_Supplement), A50-A50, 2018
12018
EVOLVE-105, a differentiated CD20-targeted CD2 co-stimulatory T cell engager engineered for the treatment of B cell malignancies
X An, M Sarkar, S Martomo, M Hackett, G Jin, T Liang, D Klaskin, T Lichter, ...
Cancer Research 84 (6_Supplement), 2369-2369, 2024
2024
Decoding the mechanisms of chimeric antigen receptor (CAR) T cell-mediated killing of tumors: insights from granzyme and Fas inhibition
MJ Montalvo, IN Bandey, A Rezvan, KL Wu, A Saeedi, R Kulkarni, Y Li, ...
Cell Death & Disease 15 (2), 109, 2024
2024
1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors
EM Tam, M Sarkar, G Jin, OA Sergeeva, A Abulizi, Z Lai, H Karp, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
Enhanced CRISPR-Cas9 edited CAR-T cells through simultaneous inactivation of multiple T cell exhaustion pathways
O Sergeeva, A Fearnley, SS Chin, X An, NA Pels, K Metzler, K Joinville, ...
Cancer Research 83 (7_Supplement), 4094-4094, 2023
2023
EVOLVETM: A novel T cell engager platform with integrated CD2 costimulation engineered for the treatment of immune suppressive tumors
M Sarkar, EM Tam, G Jin, SS Chin, A Abulizi, OA Sergeeva, Z Lai, E Teran, ...
Cancer Research 83 (7_Supplement), 2971-2971, 2023
2023
Abstract B44: EVOLVE: A novel costimulatory T cell engager platform engineered for the treatment of solid tumors
MSS Chin, M Sarkar, E Tam, A Abulizi, G Jin, X An, E Teran, DM Klaskin, ...
Cancer Immunology Research 10 (12_Supplement), B44-B44, 2022
2022
402 T cell killing is facilitated by multiple cytotoxic pathways
M Montalvo, I Bandey, A Rezvan, KL Wu, A Saeedi, Y Li, R Kulkarni, X An, ...
Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022
2022
Metabolic plasticity of T-cell therapies: multi-omic profiling of interacting human tumor-infiltrating lymphocytes and autologous tumor adoptive cell therapy
M Martinez-Paniagua, C Haymaker, J Robinson, M Harel, C Creasy, ...
bioRxiv, 2022.09. 28.509590, 2022
2022
Multiomic dynamic single-cell profiling of CAR T cell populations associated with efficacy
A Rezvan, G Romain, M Fathi, D Heeke, M Martinez-Paniagua, X An, ...
The Journal of Immunology 208 (1_Supplement), 54.18-54.18, 2022
2022
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20